Illinois SB1773 advances in House: placed on Calendar 2nd Reading (Short Debate)

Illinois SB1773 (104th General Assembly), which would amend the Illinois Controlled Substances Act to classify xylazine as a Class/Schedule III controlled substance and include specific statutory exemptions for certain veterinary/animal-drug and professional uses, advanced procedurally in the Illinois House. The ILGA bill status record shows the bill was placed on the House Calendar for 2nd Reading (Short Debate) on 2026-02-13. This is legislative progress and not enactment; compliance teams should treat the requirements as pending and monitor for passage, signature, and any finalized effective/implementation dates.